What Is Multiple Sclerosis?

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system in which the immune system attacks and damages the myelin sheaths surrounding axons in the brain, spinal cord, and optic nerves. Demyelination slows or blocks the conduction of electrical signals along nerve fibers, producing deficits in motor control, sensation, vision, and cognition that vary depending on the location and extent of lesions. MS typically presents in early adulthood and follows one of several clinical courses, ranging from relapsing-remitting patterns, in which episodes of neurological dysfunction are followed by partial or full recovery, to progressive forms characterized by steadily accumulating disability. Within the IEEE Technology Navigator context, multiple sclerosis appears as a topic because biomedical engineering contributes substantially to its diagnosis, monitoring, and treatment through imaging, signal processing, neural interfaces, and assistive technologies.

The pathophysiology of MS involves inflammatory plaques that are visible on magnetic resonance imaging, making MRI the central diagnostic and monitoring tool. The 2017 McDonald diagnostic criteria, which define the conditions under which MS can be diagnosed after a single clinical episode, rely on MRI evidence of lesion dissemination in space and dissemination in time to distinguish MS from other demyelinating conditions.

MRI Diagnostics

MRI provides the primary imaging evidence for MS diagnosis and disease monitoring. The MAGNIMS consensus guidelines for MRI-based MS diagnosis require lesions of at least 3 mm in at least one plane, distributed across at least two of five anatomical regions: periventricular white matter (at least three lesions), infratentorial structures, the spinal cord, the optic nerve, and cortical or juxtacortical regions. T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences detect hyperintense plaques with high sensitivity. Gadolinium-enhancing lesions on T1-weighted sequences indicate active inflammation with blood-brain barrier disruption, while non-enhancing T1 hypointense lesions, called black holes, reflect areas of more severe axonal loss. Higher field strengths of 3.0 and 7.0 Tesla improve detection of cortical lesions and perivenular lesion morphology, which are particularly characteristic of MS pathology. The volumetric measurement of brain atrophy, using segmentation algorithms applied to T1 images, provides a sensitive biomarker for cumulative tissue loss that correlates more closely with long-term disability than lesion counts alone.

Neuroimaging Biomarkers

Quantitative MRI techniques extend beyond conventional lesion counting to probe the microstructural integrity of brain tissue. Diffusion tensor imaging (DTI) measures water diffusion anisotropy along white matter tracts, detecting axonal injury in tissue that appears normal on conventional MRI sequences. Magnetization transfer imaging quantifies myelin content by measuring the exchange of magnetization between free water protons and protons bound to macromolecules. Magnetic resonance spectroscopy detects neurochemical abnormalities including reductions in N-acetylaspartate, a marker of neuronal integrity, and elevations in choline and myoinositol associated with demyelination and inflammation. The NIH-indexed review of quantitative MRI in multiple sclerosis describes how these advanced markers could provide outcome measures for clinical trials that are more sensitive than relapse rate or clinical disability scores.

Assistive and Therapeutic Technologies

Biomedical engineering contributes assistive technologies that help people with MS compensate for motor, communication, and cognitive deficits. EEG-based brain-computer interfaces (BCI) allow patients with severe motor impairment to control communication devices or environmental control systems using scalp-recorded neural signals without surgery. Research on brain-computer interfaces for multiple sclerosis demonstrates that non-invasive EEG platforms are preferred by most patients over invasive implants, though the progressive and variable neural changes in MS require continuous system recalibration. Functional electrical stimulation (FES) systems apply electrical pulses to peripheral muscles to restore gait in patients with foot drop, one of the most common MS-related motor deficits.

Applications

Multiple sclerosis research and technology have applications across several fields, including:

• Clinical MRI protocol development for neurological disease monitoring
• Drug trial outcome measure design using quantitative imaging biomarkers
• Brain-computer interfaces and communication aids for severely disabled patients
• Exoskeleton and functional electrical stimulation devices for gait rehabilitation
• Telemedicine platforms for remote neurological assessment and follow-up